Interaction ZPR1 Translation Elongation
Factor-1a Proliferating Cells
Laxman Gangwani, Monique Mikrut, Zoya Galcheva-Gargova, Roger J. Davis
Howard Hughes Medical Institute Program Molecular Medicine, Department Biochemistry Molecular Biology,
University Massachusetts Medical School, Worcester, Massachusetts 01605




Abstract. zinc finger protein ZPR1 present                          essential viability S. cerevisiae. yeast cytoplasm quiescent mammalian cells trans-                         ZPR1 protein redistributes cytoplasm locates nucleus treatment mitogens,                          nucleus response nutrient stimulation. Disruption
including epidermal growth factor (EGF). Homologues                           binding ZPR1 eEF-1a mutational analy- ZPR1 identified yeast mammals.                           sis resulted accumulation cells G2/M
ZPR1 proteins bind eukaryotic translation elonga-                          phase cell cycle defective growth. Reconstitution
tion factor-1a (eEF-1a). Studies mammalian cells                           ZPR1 interaction eEF-1a restored normal
demonstrated EGF treatment induces interac-                          growth. conclude ZPR1 essential cell 
tion ZPR1 eEF-1a redistribution                            bility interaction eEF-1a contributes proteins nucleus. yeast Saccharomy-                        normal cellular proliferation.
ces cerevisiae, genetic analysis demonstrated ZPR1 essential gene. Deletion analysis demonstrated                          Key words: cell cycle • eEF-1a • EGF • Saccharomy- NH2-terminal region ZPR1 required                          ces cerevisiae • zinc finger
normal growth COOH-terminal region




T
        zinc finger protein ZPR1 located                         mitogen-stimulated release ZPR1 receptors
        cytoplasm quiescent mammalian cells (Galcheva-                     trigger accumulation ZPR1 nucleus. Al-
        Gargova et al., 1996). Treatment mitogens,                       plausible hypothesis, appears including epidermal growth factor (EGF), causes                        possible mechanism represents oversimplification distribution ZPR1 cytoplasm nucleus                        processes control subcellular localization (Galcheva-Gargova et al., 1996). function ZPR1                      ZPR1.  unclear relative abundance nucleus defined.  nuclear                        receptors ZPR1 sufficient account cyto-
redistribution ZPR1 proliferating cells suggests                   plasmic sequestration ZPR1 quiescent cells. Second, protein act signaling molecule communi-                    ZPR1 lacks obvious nuclear localization sequence cates mitogenic signals cytoplasm nucleus.                    direct nuclear accumulation ZPR1 released
   mechanism cytoplasmic retention ZPR1                          receptor complexes.  present study, quiescent cells unclear. ZPR1 binds group ty-                      nuclear localization ZPR1 regulated rosine kinase receptors, including EGF platelet-                      cells lack tyrosine kinase receptors. consider-
derived growth factor receptors (Galcheva-Gargova et al.,                     ations suggest interaction ZPR1 bio-
1996). binding ZPR1 receptors blocked                      molecules contribute regulation subcel- mitogen stimulation (Galcheva-Gargova et al., 1996).                    lular distribution ZPR1. possible ZPR1 sequestered                         known ZPR1 binds cell surface  cytoplasm receptors quiescent cells                    ceptor molecules quiescent cells, established
                                                                              effect mitogens inhibit ZPR1/recep-
                                                                              tor interaction represents formation novel ZPR1
                                                                              complex different protein. purpose study
                                                                              described report identify protein inter-
                                                                              acts ZPR1 treatment cells mitogens. Address correspondence R.J. Davis, Howard Hughes Medical Institute,
Program Molecular Medicine, University Massachusetts Medical            study facilitated identification ZPR1 homo-
School, 373 Plantation St., Worcester, MA 01605. Tel.: (508) 856-6054.        logues mammals yeast.
Fax: (508) 856-3210. E-mail: roger.davis@ummed.edu                               report ZPR1 binds eukaryotic translation



 Rockefeller University Press, 0021-9525/98/12/1471/14 $2.00 Journal Cell Biology, Volume 143, Number 6, December 14, 1998 1471–1484
http://www.jcb.org                                                             1471
 Table  Plasmids
Plasmids                                                 Description                                                    Source

YCp50                                   URA3, ARS1, CEN4                                                   Rose et al., 1987
pRS317                                  LYS2, ARSH4, CEN6                                                  Sikorski Boeke, 1991
pRS405                                  LEU2                                                               Sikorski Hieter, 1989
pRS426                                  URA3, 2 m                                                          Christianson et al., 1992
p413ADH                                 HIS3, ARSH4, CEN6 ADH promoter                                American Type Culture Collection
pLG1                                    YCp50 genomic cZPR1                                           study
pLG2                                    pBS cZPR1                                                     study
pLP1                                    pGEX-3X cZPR1                                                 study
pLP2                                    pGEX-5X-1 TEF1                                                study
pLP3                                    pCAL-n cZPR1                                                  study
pLP4                                    pCAL-n mZPR1 (1–774)                                          study
pLPNT                                   pCAL-n cZPR1 (1–780)                                          study
pLPCT                                   pCAL-n cZPR1 (781–1,458)                                      study
pLPD1                                   pCAL-n cZPR1 D (664–723)                                      study
pLPD2                                   pCAL-n cZPR1 D (664–783)                                      study
pLDP3                                   pCAL-n cZPR1 D (604–723)                                      study
pLDP4                                   pCAL-n cZPR1 D (604–783)                                      study
pLPD5                                   pCAL-n cZPR1 D (604–663)                                      study
pLC1                                    p413ADH cZPR1                                                 study
pLCNT                                   p413ADH cZPR1 (1–780)                                         study
pLCCT                                   p413ADH cZPR1 (781–1,458)                                     study
pLCCT2                                  pRS317 ADH promoter, cZPR1 (781–1,458)                        study
pLCD1                                   p413ADH cZPR1 D (664–723)                                     study
pLCD2                                   p413ADH cZPR1 D (664–783)                                     study
pLCD3                                   p413ADH cZPR1 D (604–723)                                     study
pLCD4                                   p413ADH cZPR1 D (604–783)                                     study
pLCD5                                   p413ADH cZPR1 D (604–663)                                     study
pLCNT2                                  p413ADH cZPR1 (1–780) D (604–663)                             study
pLCG1                                   p413ADH cZPR1 D (604–663), GFP                                study
pLCG2                                   p413ADH cZPR1 (1–780), GFP                                    study
pLCG3                                   p413ADH cZPR1 (781–1,485), GFP                                study
pMM6                                    pRS405 cZPR1 (2785 210), (970–1,471)                       study
pMM13                                   pRS426 GAL promoter, cZPR1                                    study
pMM29                                   p413ADH cZPR1 (294, 297 C                                   study
pMM36                                   p413ADH cZPR1 (54, 57 C                                     study
pMM38                                   pRS317 ADH promoter, cZPR1 (1–780)                            study
pMM48                                   p413ADH GFP                                                   study
pMM49                                   p413ADH cZPR1, GFP                                            study
pZPP                                    pGEX-3X pZPR1                                                 study
pLZM1–7                                 pGEX-5X-1 mZPR1 (fragments 1–7)                               Galcheva-Gargova et al., 1996
pZM2                                    pCDNA3 Flag-mZPR1                                             Galcheva-Gargova et al., 1996
pZPM                                    pGEX-3X mZPR1                                                 Galcheva-Gargova et al., 1996


elongation factor-1a (eEF-1a).1 EGF stimulation mam-                    binding ZPR1 eEF-1a mutational analysis
malian cells triggers formation ZPR1/eEF-1a com-                       caused accumulation cells G2/M phase plexes translocation ZPR1 eEF-1a                       cell cycle defective growth. Reconstitution cytoplasm nucleus. Similarly, yeast                 ZPR1 interaction eEF-1a inter-allelic complemen-
S. cerevisiae, ZPR1 redistributes cytoplasm                    tation restored normal growth. data establish role nucleus response nutrient stimulation. Dis-                  formation nuclear ZPR1/eEF-1a complexes ruption ZPR1 gene lethal S. cerevisiae. Dele-                 normal growth proliferating cells.
tion analysis demonstrated ZPR1 divided                      Previous studies demonstrated eEF-1a plays functional domains. NH2-terminal region                         pivotal role protein biosynthesis (Moldave, 1985). ad-
ZPR1 required normal growth COOH-                       dition, eEF-1a known involved diverse cellular
terminal region essential viability. Disruption              processes, including embryogenesis (Krieg et al., 1989), se-
                                                                           nescence (Shepherd et al., 1989), oncogenic transforma-
                                                                           tion (Tatsuka et al., 1992), cell proliferation (Sanders et
1. Abbreviations used paper: CBP, calmodulin-binding protein;      al., 1996), organization cytoskeleton (Condee-
CT, COOH-terminal region ZPR1; cZPR1, S. cerevisiae ZPR1; DAPI,         lis, 1995; Edmonds et al., 1996). eEF-1a present mainly
496-diamidino-2-phenylindole; eEF-1a, eukaryotic translation elongation    cytoplasm cells (Edmonds et al., 1996; Minella et
factor-1a; GFP, green fluorescent protein; GST, glutathione-S-trans-
ferase; mZPR1, mouse ZPR1; NT, NH2-terminal region ZPR1; PMA,
                                                                           al., 1996), small population eEF-1a molecules phorbol 12-myristate 13-acetate; PVDF, polyvinylene difluoride; pZPR1,     previously identified nucleus (Colling et al.,
S. pombe ZPR1.                                                             1994; Janssen et al., 1994; Barberse et al., 1995; Billaut-



 Journal Cell Biology, Volume 143, 1998                              1472
 Mulot et al., 1996; Sanders et al., 1996). Recently, eEF-1a                  ADH SmaI/EcoRI sites create plasmid pMM48. cZPR1 shown bind viral RNA (Blackwell Brinton,                          fragment (BglII-SmaI) amplified PCR cloned pMM48                                                                              BamHI/SmaI sites create plasmid pMM49. S. cerevisiae gene
1997) RNA polymerases (Blumenthal Carmi-                             encoding translation elongation factor eEF-1a (TEF1) amplified chael, 1979; Das et al., 1998).                                              PCR using genomic DNA template cloned pGEX-5X-1
  involvement eEF-1a nuclear processes                          (Pharmacia Biotech) BamHI site. frame deletions prepared
mains established. results present study                    using standard PCR-based procedures. plasmids used study                                                                              summarized Table 
suggest physiological functions eEF-1a                       Recombinant plasmids express fusion proteins calmodulin-
nucleus include complex formation ZPR1 mi-                       binding protein (CBP) glutathione-S-transferase (GST) ex-
togen-treated cells.                                                         pressed BL21 (DE3) bacteria BL21 bacteria, respectively.                                                                              fusion proteins induced 1 mM IPTG 2 h 308C                                                                              purified affinity chromatography.
Materials Methods
                                                                             Disruption ZPR1 Gene
Preparation Recombinant Plasmids Proteins                             Yeast manipulated according standard procedures. diploid yeast ZPR1 gene isolated screening S. cerevisiae genomic       strain (MY2) heterozygous ZPR1 gene disruption constructed
library (prepared Rose et al., 1987) using colony screening. 300-bp     using established techniques (Rothstein, 1993). recombinant plasmid
fragment, amplified using polymerase chain reaction (PCR),      pMM6 prepared inserting fragments cZPR1 gene (2785
right arm chromosome VII S. cerevisiae used preparing      bp 210 bp 1970 bp 11,471 bp) flanking LEU2 gene [32P]labeled probe hybridization (Prime II; Stratagene, La Jolla,     plasmid pRS405 (Sikorski Hieter, 1989). ScaI-SpeI fragment
CA). Positive clones examined automated sequencing (model            pMM6 containing disrupted cZPR1 gene transformed 373A; Applied Biosystems, Foster City, CA). S. pombe zpr11 gene          diploid yeast strain CY246 (obtained C.L. Peterson, University isolated using similar procedure (Galcheva-Gargova et al., 1998).      Massachusetts Medical School, Worcester, MA). Southern blots Subsequently, open reading frame encoding S. cerevisiae ZPR1             Leu1 transformants identified colonies heterozygous cZPR1 dis-
(YGR211w) identified S. cerevisiae genome (GenBank/EMBL/          ruption. heterozygote MY2 sporulated tetrads dis-
DDBJ accession number Z72996). nucleotide sequence cloned         sected. spores showed 2:2 segregation viability 
ZPR1 gene YGR211w identical. Standard recombinant DNA               ble spores Leu1, indicating disruption cZPR1 gene
techniques used construct fusion proteins. coding region S.   lethal. isolate haploid yeast cZPR1 disrupted gene (zpr1::
cerevisiae ZPR1 (cZPR1) amplified PCR cZPR1 genomic          LEU2), yeast strain MY2 (diploid) transformed plasmid
clone (pLG1) template subcloned plasmid pBS            pMM13 (ZPR1 control GAL promoter URA1 plasmid),
(Stratagene) XhoI fragment SalI site (pLG2). cZPR1         sporulated, tetrads dissected. Leu1 Ura1 haploid cells
fragment cloned XhoI (blunt-ended)-EcoRI fragment             (zpr1::LEU2) complemented wild-type cZPR1 plasmid pMM13
pLG2) pGEX-3X (Pharmacia Biotech, Piscataway, NJ) SmaI/            selected designated strain MY7. Mutant cZPR1 genes EcoRI sites. length (wild-type) truncated cZPR1, amplified       introduced strain MY7 plasmid shuffling (Sikorski Boeke,
PCR, cloned pCAL-n (Stratagene) p413ADH (American                1991) using 59-fluoroorotic acid (Toronto Research Chemicals, North
Type Culture Collection, Rockville, MD) expression vectors SmaI/      York, Ontario, Canada). Yeast strains wild-type mutant cZPR1
EcoRI sites. Mouse ZPR1 (mZPR1), length truncated fragments         listed Table II.
amplified PCR, cloned pCAL-n EcoRI/XhoI sites.
S. pombe ZPR1 (pZPR1) PCR amplified cloned pGEX-3X             Mammalian Cell Culture BamHI/EcoRI sites. Mutant green fluorescent protein (GFP) (S65T,
V163A; Anderson et al., 1996) PCR amplified cloned p413           COS-7 A431 cells maintained Dulbecco’s modified Eagle’s


Table II. Saccharomyces cerevisiae Strains
Strain                                                        Genotype                                                                   Source

L40        MATa his3D200 trp1-901 leu2-3,112 ade2 LYS2:: (lexAop)4 URA3::(lexAop)8-LacZ                                 Vojtek et al., 1993
CY246      MATa/MATa lys2-801/lys2-801 ade2-101/ade2-101 leu2-D1/leu2-D1 his3-D200/his3-D200 ura3-D99/ura3-D99              C.L. Peterson,
                                                                                                                            University Massachusetts
                                                                                                                            Medical School,
                                                                                                                            Worcester, MA
MY2        MATa/MATa lys2-801/lys2-801 ade2-101/ade2-101 leu2-D1/leu2-D1/his3-D200/his3-D200 ura3-D99/ura3-D99              study
            zpr1::LEU2/ZPR1
MY7        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM13                                               study
MY28       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM49                                               study
LY1        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLC1                                                study
LY2        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD1                                               study
LY3        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD2                                               study
LY4        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD3                                               study
LY5        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD4                                               study
LY6        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD5                                               study
LY7        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD3, pMM38                                        study
LY8        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD5, pMM38                                        study
LY9        MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT                                               study
LY10       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT, pMM38                                        study
LY11       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCG1                                               study
LY12       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM13, pLCG2                                        study
LY13       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT2, pLCNT2                                      study
LY14       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCG3, pMM38                                        study
MY17       MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM36                                               study




Gangwani et al. Interaction ZPR1 eEF-1a                               1473
 medium, 2 mM glutamine, 100 U/ml penicillin 100 U/ml streptomycin          Upstate Biotechnology. cells washed PBS-T (0.2 
supplemented 10  heat-inactivated fetal bovine serum (COS-7 cells)        Tween-20) times incubated conjugated secondary anti- 5  calf serum (A431 cells) (Life Technologies, Gaithersburg, MD).           bodies (goat cyanine [Cy3]-labeled anti-rabbit IgG goat fluorescein cells grown 378C humidified atmosphere 5  CO2.           [FITC]-labeled anti-mouse IgG; Jackson ImmunoResearch Laboratories,
Transfection plasmid pCDNA3-Flag-mZPR1 (Galcheva-Gar-                 West Grove, PA) 1 h washed times PBS-T (0.2 
gova et al., 1996) performed using Lipofectamine (Life Technologies)       Tween-20). Coverslips mounted slides using Vectashield (Vector
according manufacturer’s instructions. A431 cells grown         Laboratories, Burlingame, CA) examined double-label immuno-
50–60  confluence starved serum-free medium 24 h. cells         fluorescence microscopy using conventional microscope (Carl Zeiss , treated 100 nM EGF PMA 5–60 min 378C.                      Thornwood, NY).
                                                                                  Haploid yeast cells disrupted zpr1::LEU2 gene trans-
Binding Assays                                                                 formed plasmids expressing wild-type cZPR1, mutated cZPR1,                                                                                cZPR1 fusion proteins GFP. Cells grown synthetic media
Binding assays performed using CBP GST fusions [35S           glucose (2 ). Log-phase cultures diluted (0.5 OD600) thionine-labeled -unlabeled cell lysates. cell extracts pre-      starved glucose-free medium 12 h 308C. Glucose (2 ) added
pared lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM            cells incubated 308C 2 h. cells harvested b-mercaptoethanol, 1.0 mM MgCl2, 1.0 mM CaCl2, 1.0 mM imidazole,               stained 496-diamidino-2-phenylindole (DAPI). GFP DAPI
0.1  Triton X-100, 1.0 mM PMSF, 1.0 mM benzamidine, 1 mM sodium                fluorescence examined conventional microscopy (Carl Zeiss ).
orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml bestatin,      Image analysis performed using software NIH Image
10 mg/ml antipain, 1.0 mg/ml pepstatin  1.0 mg/ml chymostatin).          (v 1.61/PPC; Bethesda, MD).
CBP GST fusions (5 mg) immobilized calmodulin affinity
resin (Stratagene) glutathione agarose beads (Pharmacia Biotech), 
spectively. beads (20 ml) washed twice 48C incubated                                                                                Flow Cytometry
cell extracts (300–500 mg protein) 2 h 500 ml lysis buffer 48C   Samples prepared flow cytometry (Lew et al., 1992). Cells (106) washed times. beads boiled Laemmli sample             pelleted, washed twice PBS, resuspended 100 ml PBS, buffer 3 min, centrifuged, supernatant examined        added dropwise 70  ethanol (1.5 ml) vortexing. cells
SDS-PAGE.                                                                      fixed overnight 70  ethanol 48C, washed PBS,                                                                                digested 1 mg/ml RNase 50 mM Tris-HCl, pH 8.0, 1 h 378C
Mass Spectroscopy                                                              followed 5 mg/ml pepsin 55 mM HCl 30 min 378C. cells
                                                                               washed PBS, stained propidium iodide, analyzed. 50-kD ZPR1 binding protein purified human A431 epider-
moid carcinoma cells S. cerevisiae strain L40 affinity chromatogra-
phy using immobilized CBP-ZPR1 (residues 1–268). Bound proteins           Results
separated SDS-PAGE electrotransferred polyvinylene di-
fluoride (PVDF) membrane (Applied Biosystems). membrane stained Ponceau S 50-kD protein excised, rinsed                                                                                Zinc Finger Protein ZPR1 Conserved water, air dried. protein digested l-tosylamido-         Mammals Yeast
2-phenyl ethyl chloromethyl ketone-treated trypsin subjected mass
spectroscopic analysis using matrix-assisted laser desorption ioniza-
                                                                               Homologues mammalian zinc finger protein ZPR1
tion time flight (MALDI-TOF) technique. Masses poly-            identified cloned yeast S. cerevisiae peptides obtained compared MS-Fit data base (Ludwig              Schizosaccharomyces pombe. sequence mouse,
Institute Cancer Research University College London mass spec-         S. cerevisiae S. pombe ZPR1 proteins deduced
troscopy facility, London, UK).                                                nucleotide sequence DNA clones (Fig. 1 .
                                                                               Comparison ZPR1 proteins indicates conserved
Immunoprecipitation Immunoblotting                                         structure including similar zinc fingers (ZnF1 Cell extracts prepared using Triton lysis buffer (20 mM Tris-HCl, pH 7.4,      ZnF2) similar regions zinc finger (Fig. 1 B,
137 mM NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 2 mM sodium                  B). mouse ZPR1 (mZPR1) protein 46 
pyrophosphate, 1  Triton X-100, 10  glycerol, 1 mM PMSF, 1 mM 
dium orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin)                                                                                identical 72  similar S. cerevisiae ZPR1 (cZPR1)
used immunoprecipitation studies. Antibodies mouse ZPR1 (Gal-           43  identical 70  similar S. pombe ZPR1
cheva-Gargova et al., 1996), eEF-1a (Upstate Biotechnology, Lake Placid,       (pZPR1). yeast proteins 55  identical NY) Flag (M2; Eastman-Kodak, Rochester, NY) prebound               78  similar. high level homology yeast
20 ml protein Sepharose (Pharmacia Biotech). beads incu-
                                                                               mammalian ZPR1 suggests overall structure
bated cell lysate 2 h, washed times, boiled Laemmli sample buffer gel electrophoresis. Bound proteins sepa-         protein conserved lower higher eu-
rated SDS-PAGE (10 ) electrotransferred PVDF membranes              karyotes.
(0.45 mm; Millipore, Waters Chromatography, Milford, MA). Antibody
incubations carried Tris-buffered saline 0.5  Tween-20        ZPR1 Essential Gene S. cerevisiae 20  horse serum. rabbit anti-ZPR1 mouse anti–eEF-1a 
tibodies diluted 1:400 1:1,000, respectively. HRP-conjugated          examined gene encoding cZPR1 es-
donkey anti–rabbit IgG sheep anti–mouse IgG (1:5,000) secondary            sential cell viability S. cerevisiae. DNA fragment
antibodies detected enhanced chemiluminescence (Amersham
International, Little Chalfont, UK).
                                                                               containing cZPR1 gene disrupted LEU2 gene
                                                                               (Fig. 2  transformed diploid yeast strain
Fluorescence Microscopy                                                        CY246. Colonies selected plates lacking leucine
                                                                               disruption genomic copy cZPR1 A431 cells cultured glass coverslips coated poly-l-lysine.                                                                                confirmed Southern blot analysis (Fig. 2 B). dip-
cells incubated serum-free medium 24 h, starved, treated 100 nM EGF PMA 378C 15 min. Coverslips             loid yeast strain MY2, heterozygous wild-type
rinsed phosphate-buffered saline (PBS) briefly chilled      cZPR1 (ZPR1/zpr1::LEU2), sporulated tet-
methanol. cells fixed 2208C methanol 5 min,           rads dissected. tetrads analyzed, viable acetone 2 min. coverslips blocked 10  horse        progeny segregated 2:2, surviving spores
serum PBS 0.5  Tween-20 (PBS-T) 30 min 258C Coplin
jars incubated primary antibodies 1 h 258C. rabbit
                                                                               Leu1 (disrupted cZPR1). data indicate
polyclonal antibody ZPR1 described (Galcheva-Gargova et            cZPR1 gene essential viability (Fig. 2 C). al., 1996). mouse monoclonal antibody eEF-1a purchased              establish loss viability disruption



 Journal Cell Biology, Volume 143, 1998                                  1474
                                                                     Figure 2. ZPR1 essential gene yeast S. cerevisiae.  
                                                                    S. cerevisiae diploid WT strain (CY246) used create
                                                                    heterozygous strain MY2 (ZPR1/zpr1::LEU2). struc-
                                                                    tures wild-type disrupted cZPR1 genes illustrated.
                                                                    (B) Disruption ZPR1 allele confirmed Southern
                                                                    blot analysis PvuI restricted genomic DNA isolated                                                                     diploid WT strain CY246 heterozygous strain MY2
                                                                    (ZPR1/zpr1::LEU2). (C) heterozygous diploid strain MY2
                                                                    (ZPR1/zpr1::LEU2) sporulated randomly selected
                                                                    asci dissected examined viability YEPD agar
                                                                    media.


Figure 1. Identification ZPR1 homologues mammals yeast.   sequence S. cerevisiae, S. pombe, mouse
ZPR1 proteins deduced nucleotide sequence DNA           mouse, S. cerevisiae S. pombe ZPR1 proteins (Fig. 3
clones presented. Residues identical sequence mouse    . Similar results obtained binding assays using
ZPR1 indicated period (.). Gaps introduced     [35S]methionine extracts prepared COS-7, CHO, sequences optimize alignment (-). Overline, zinc fin-    S. cerevisiae (strain L40) cells (data shown). gers; asterisks, Cys residues. sequences mouse ZPR1, S.
                                                                    data indicate yeast mammalian ZPR1 pro-
pombe zpr1 S. cerevisiae ZPR1 deposited GenBank/EMBL/DDBJ accession numbers U41287, AF019768                teins similar biochemical properties, including AF019769, respectively. (B) Schematic representation     interaction 50-kD protein.
predicted domain structure ZPR1. regions required        Deletion analysis mouse ZPR1 using [35S]methionine
teraction EGF receptor indicated (EGF-R).              cell extracts demonstrated NH2-terminal mZPR1
                                                                    fragment (ZnF1  residues 1–268) sufficient bind-
                                                                    ing 50-kD protein (data shown). fragment                                                                     mZPR1 used isolate 50-kD protein human cZPR1 gene, complemented haploid yeast               (A431) S. cerevisiae (L40) cell extracts affinity disrupted cZPR1 gene (zpr1::LEU2) using plasmid               chromatography. bound proteins resolved expressing wild-type cZPR1. data demonstrated                 SDS-PAGE electrotransferred PVDF mem- cZPR1 gene essential viability S. cerevi-       brane. 50-kD protein digested l-tosylamido-
siae.                                                               2-phenyl ethyl chloromethyl ketone-treated trypsin                                                                     examined mass spectroscopy using MALDI-TOF
Identification eEF-1a ZPR1-binding Protein                  technique. comparison masses polypep- study interaction ZPR1 proteins,            tides obtained MS-Fit data base led identi-
performed vitro binding assays using [35S]methionine             fication 50-kD protein eEF-1a (Table III).
human A431 epidermoid carcinoma cell extracts im-                  confirm identification 50-kD protein mobilized GST–ZPR1 fusion proteins. expected,                eEF-1a, examined proteins bound mZPR1
mouse ZPR1 protein bound 180-kD EGF receptor                 Western blot analysis using antibody eEF-1a. Im-
(Fig. 3 . addition, [35S]methionine pro-         mobilized recombinant mZPR1 bind eEF-1a
teins observed bind ZPR1. particular, 50-kD            (Fig. 3 B, lane 8). Similarly, immobilized recombinant
protein prominently detected binding assays using            eEF-1a bound mZPR1 (Fig. 3 C). Deletion analysis




Gangwani et al. Interaction ZPR1 eEF-1a                      1475
                                                                                                        Figure 3. ZPR1 binds eEF-
                                                                                                       1a vitro.   A431 cells
                                                                                                       labeled [35S 
                                                                                                       thionine. Soluble extracts
                                                                                                       prepared incubated
                                                                                                          immobilized      ZPR1
                                                                                                       (GST–ZPR1) proteins                                                                                                        species: S. cerevisiae, S.
                                                                                                       pombe, mouse. Bound
                                                                                                       proteins examined                                                                                                        SDS-PAGE autoradiog-
                                                                                                       raphy. Arrows, binding                                                                                                        180-kD EGF receptor                                                                                                        mouse ZPR1 promi-
                                                                                                       nent 50-kD protein binds
                                                                                                       mouse yeast ZPR1
                                                                                                       proteins. (B) Deletion analy-
                                                                                                       sis mZPR1 sequences 
                                                                                                       quired interaction                                                                                                        eEF-1a. Immobilized GST
                                                                                                       GST–mZPR1 fusion pro-
                                                                                                       teins incubated cell
                                                                                                       lysates. Bound eEF-1a detected protein immunoblot analysis using monoclonal antibody eEF-1a. binding eEF-1a length (lane 8) truncated (lanes 1–7) mZPR1 proteins presented. mZPR1 amino acid residues truncated constructs  1–99 (1); 94–268
(2); 263–306 (3); 302–469 (4); 1–268 (5); 263–469 (6); 1–306 (7); 1–469 (8). (C) Recombinant eEF-1a binds mZPR1 vitro. Im-
mobilized GST GST–eEF-1a incubated cell lysates. Bound mZPR1 detected protein immunoblot analysis using rabbit polyclonal antibody mZPR1. multiple bands characteristic electrophoretic mobility mZPR1 (Galcheva-Gar-
gova et al., 1996). (D) Binding recombinant eEF-1a cZPR1. Immobilized GST GST–eEF-1a incubated purified
CBP–cZPR1. Bound cZPR1 detected protein immunoblot analysis.


demonstrated NH2-terminal region mZPR1                                    (data shown). test ZPR1 eEF-1a bind sufficient binding eEF-1a (Fig. 3 B). Deletion                                directly, performed vitro assays using puri-
analysis eEF-1a demonstrated NH2-terminal                                 fied recombinant proteins. analysis demonstrated
region (residues 1–300) required binding ZPR1                                 eEF-1a directly binds cZPR1 (Fig. 3 D).

Table III. Identification 50-kD ZPR1-binding Protein Mass Spectroscopy
Mass submitted                            Mass matched                                         Peptide sequences                                       Protein matched

Saccharomyces cerevisiae
  1026.0000                                1026.2286                      (K) IGGIGTVPVGR (V)
  1494.0000                                1492.7675                      (K) YAWVLDKLKAER (E)
  1563.0000                                1561.7876                      (K) SHINVVVIGHVDSGK (S)
  1861.0000                                1860.1303                      (K) YQVTVIDAPGHRDFIK (N)
  2326.0000                                2326.7513                      (K) FVPSKPMCVEAFSEYPPLGR (F)                                                    eEF-1a
  2365.0000                                2364.7137                      (K) TLLEAIDAIEQPSRPTDKKPLR (L)                                               (50032.9 kD)
  2432.0000                                2431.9076                      (R) VETGVIKPGMVVTFAPAGVTTEVK (S)
  2552.0000                                2551.8068                      (K) SVEMHHEQLEQGVPGDNVGFNVK (N)
  2911.0000                                2910.2887                      (K) TVPFVPISGWNGDNMIEATTNAPWYK (G)
  3320.0000                                3321.8552                      (K) TLLEAIDAIEQPSRPTDKPLRLPLQDVYK  

Human
   815.6000                                 816.9392                      (K) EKIDRR (S)
   959.0000                                 960.1287                      (K) IDRRSGKK (L)
   959.0000                                 960.1256                      (K) SAQKAQKAK (–)
  1026.0000                                1026.2286                      (K) IGGIGTVPVGR (V)
  1121.0000                                1121.2830                      (K) STTTGHLIYK (C)                                                              eEF-1a
  1315.5000                                1314.5320                      (K) GSFKYAWVLDK (L)                                                          (50127.1 kD)
  1315.5000                                1315.5608                      (R) EHALLAYTLGVK (Q)
  1405.8000                                1405.6019                      (K) YYVTIIDAPGHR (D)
  1405.8000                                1405.6461                      (K) FAELKEKIDRR (S)
  1590.3000                                1589.8416                      (K) THINIVVIGHVDSGK (S)
  2517.6001                                2517.0136                      (R) VETGVLKPGMVVTFAPVNVTTEVK (S)
  3011.8000                                3011.4769                      (R) KSGDAIVDMVPGKPMCVESPSDYPPLGR (F) 50-kD protein purified affinity chromatography SDS-PAGE. protein electroblotted PVDF membrane, digested L-tosylamido-2-phenyl ethyl
chloromethyl ketone-treated trypsin, subjected mass spectroscopy using MALDI-TOF technique. Peptide masses obtained compared MS-Fit data-
base.



 Journal Cell Biology, Volume 143, 1998                                         1476
 Interaction eEF-1a ZPR1 Vivo                              Fig. 4 shows eEF-1a coimmunoprecipitated
                                                                    ZPR1. Control experiments using cells did test eEF-1a ZPR1 interact vivo,
                                                                    express epitope-tagged mZPR1 demonstrated coimmu- performed coimmunoprecipitation analysis. Epitope-
                                                                    noprecipitation eEF-1a. data indicate ZPR1
tagged mZPR1 immunoprecipitated serum-
                                                                    eEF-1a interact vivo.
treated COS-7 cells presence eEF-1a im-
                                                                       ZPR1 shown bind EGF receptor qui-
munoprecipitates examined Western blot analysis.
                                                                    escent cells released receptor                                                                     treatment EGF (Galcheva-Gargova et al. 1996). EGF
                                                                    regulate interaction ZPR1 eEF-
                                                                    1a. examine effect EGF, starved A431 cells
                                                                    serum-free medium 24 h treated cells
                                                                    100 nM EGF. eEF-1a immunoprecipitated                                                                     presence ZPR1 detected Western blot analy-
                                                                    sis. Coimmunoprecipitation ZPR1 eEF-1a                                                                     detected EGF-treated cells, serum-
                                                                    starved cells (Fig. 4 B). coimmunoprecipi-
                                                                    tated ZPR1 sustained longer periods treat-
                                                                    ment EGF (Fig. 4 C). data indicate EGF
                                                                    induces interaction ZPR1 eEF-1a. test
                                                                    interaction ZPR1 eEF-1a                                                                     induced stimuli, studied effect serum.
                                                                    Treatment serum-starved cells fetal calf serum
                                                                    (10 ) resulted coimmunoprecipitation ZPR1
                                                                    eEF-1a (Fig. 4, B C). Based observa-
                                                                    tions, propose growth signals mitogen-activated
                                                                    cells induce formation eEF-1a/ZPR1 com-
                                                                    plexes vivo. Specificity formation eEF-1a/
                                                                    ZPR1 complex established observation                                                                     treatment cells tumor promoter phorbol
                                                                    12-myristate 13-acetate (PMA) did cause coimmuno-
                                                                    precipitation ZPR1 eEF-1a (Fig. 4 B).

                                                                    Redistribution ZPR1 eEF-1a Nucleus                                                                     Mitogen-activated Mammalian Cells
                                                                    examined subcellular localization ZPR1                                                                     eEF-1a mammalian cells double-label immunofluo-
                                                                    rescence microscopy. Consistent previous studies
Figure 4. Coimmunoprecipitation analysis demonstrates          (Galcheva-Gargova et al., 1996) observed ZPR1
eEF-1a ZPR1 interact vivo.   COS-7 cells mock-        (red) redistributed cytoplasm nucleus transfected (CONTROL) transfected vector expressing       EGF stimulation serum-starved cells (Fig. 5). eEF-1a epitope-tagged ZPR1. Flag-ZPR1 immunoprecipitated          abundant protein present mainly cyto- M2 monoclonal antibody. eEF-1a immunoprecipitates        plasm cells (Edmonds et al., 1996). Fig. 5 shows (IP) detected protein immunoblot analysis mono-       effect EGF treatment subcellular distribution
clonal antibody eEF-1a. (B) Coimmunoprecipitation ZPR1        eEF-1a (green). serum-starved cells, eEF-1a eEF-1a cells treated serum EGF. A431 epider-      present cytoplasm. treatment EGF, moid carcinoma cells incubated serum-free medium                                                                     fraction eEF-1a molecules observed redis-
24 h. cells untreated treated 5  calf serum, 100
nM EGF, 100 nM PMA 15 min. Extracts prepared            tribute cytoplasm nucleus. distribution cells eEF-1a isolated immunoprecipitation.      eEF-1a ZPR1 nucleus treatment cells
Specificity immunoprecipitation examined using mock      EGF similar, represented yellow fluores-
immunoprecipitates prepared using protein Sepharose beads         cence merged images ZPR1 eEF-1a (Fig. 5). antibody eEF-1a (CONTROL). ZPR1 immuno-           Similar results obtained treatment serum-
precipitates detected protein immunoblot analysis using    starved cells 10  calf serum (data shown). Quan-
rabbit polyclonal antibody. (C) EGF causes rapid formation      titative analysis fluorescence images demonstrated ZPR1/eEF-1a complexes detected coimmunopre-          ZPR1 z98  cytoplasmic serum-starved cells
cipitation analysis. A431 cells serum starved 24 h.    z96  nuclear EGF-treated cells. Similar anal-
cells incubated 100 nM EGF various times, extracts
                                                                    ysis demonstrated eEF-1a detected nu- prepared, eEF-1a isolated immunopre-
cipitation. Specificity immunoprecipitation examined     cleus serum-starved cells z5  total
using mock immunoprecipitates prepared using protein Seph-        eEF-1a located nucleus stimulation arose beads antibody eEF-1a (CONTROL). pres-         EGF. data indicate ZPR1 eEF-1a ence ZPR1 immunoprecipitates examined pro-         located nucleus mitogen-treated cells. punc-
tein immunoblot analysis rabbit polyclonal antibody.         tate distribution ZPR1 nucleus previously




Gangwani et al. Interaction ZPR1 eEF-1a                      1477
                                                                                             Figure 5. Redistribution                                                                                             eEF-1a ZPR1                                                                                             cytoplasm nucleus                                                                                             EGF-treated cells. A431
                                                                                            cells incubated se-
                                                                                            rum-free medium 24 h
                                                                                            (starved) treated
                                                                                            100 nM EGF 100 nM
                                                                                            PMA 15 min 378C.                                                                                             cells fixed, permeabi-
                                                                                            lized, examined                                                                                             double-label immunofluores-
                                                                                            cence microscopy. Fluores-
                                                                                            cein (green) cyanine
                                                                                            (red) represent eEF-1a                                                                                             ZPR1, respectively. Yellow,
                                                                                            colocalization eEF-1a                                                                                             ZPR1 nucleus                                                                                             EGF treatment merged
                                                                                            images. Bar, 50 mm.



demonstrated correspond accumulation         (Venema et al., 1991).  PMA did cause punc-
nucleoli (Galcheva-Gargova et al., 1996). nucleolar     tate nuclear accumulation eEF-1a ZPR1 (Fig. 5).
accumulation characterized colocalization ZPR1      data consistent results coimmuno- fibrillarin RNA polymerase  splic-   precipitation analysis treatment PMA did ing factor SC35 p80 coilin (Galcheva-Gargova et al.,      induce formation ZPR1/eEF-1a complexes (Fig. 4
1998).                                                       B). conclude ZPR1 responds selective extracel-
  studied effect PMA subcellular distri-    lular stimuli.
bution eEF-1a ZPR1 confirm specificity interaction eEF-1a ZPR1 response extracellular stimulation. PMA known induce                                                              Nuclear Redistribution ZPR1 Yeast
phosphorylation eEF-1a activating protein kinase C     study localization cZPR1 yeast S. cerevi-



                                                                                            Figure 6. Redistribution                                                                                             ZPR1 yeast S. cerevi-
                                                                                            siae. haploid yeast strain
                                                                                            MY28 (Table III) examined
                                                                                            fluorescence microscopy.
                                                                                            yeast strain expresses
                                                                                            cZPR1–GFP absence
                                                                                            wild-type cZPR1. cells
                                                                                            grown synthetic 
                                                                                            dium glucose  
                                                                                            TROL) starved glu-
                                                                                            cose-free medium 12 h
                                                                                            (STARVED). Glucose (2 )
                                                                                            added starved cells
                                                                                            incubated 2 h (GLU-
                                                                                            COSE). GFP (green)
                                                                                            DAPI (blue) represents
                                                                                            ZPR1 DNA, respec-
                                                                                            tively. Bar, 10 mm.



 Journal Cell Biology, Volume 143, 1998                1478
 siae, recombinant cZPR1–GFP fusion gene 
structed. cZPR1–GFP gene complemented loss viability yeast disrupted zpr1::LEU2 gene. haploid yeast expressing cZPR1–GFP fusion
protein examined fluorescence microscopy. 
trol experiments demonstrated GFP sequestered vacuole yeast expressing GFP (data shown). Fig. 6 shows cZPR1–GFP fusion protein
(green) present mainly nucleus S. cerevisiae
(CONTROL). Starvation yeast glucose-free 
dium caused redistribution cZPR1 nucleus cytoplasm (Fig. 6). Readdition glucose starved cells induced translocation cZPR1 cytoplasm nucleus. localization redistribu-
tion ZPR1 response nutrients S. cerevisiae ap-
pears similar observed starved mito-
gen-treated mammalian cells.  possible cZPR1 function signaling molecule S. cerevi-
siae responds proliferation signals.

Identification Mutant ZPR1 Molecules Fail Interact eEF-1a examine interaction ZPR1 eEF-1a, 
formed deletion analysis cZPR1. Studies using NH2-ter-
minal (NT) COOH-terminal (CT) fragments cZPR1
demonstrated eEF-1a–binding site located NH2-terminal region cZPR1 (residues 1–261) (Fig.
7, B). constructed series COOH-terminal
truncated mutants NT fragment cZPR1. Binding
assays indicated cZPR1 residues 202–261 
quired interaction eEF-1a cZPR1 (data shown). Subsequently, series frame deletion mu-
tants length cZPR1 (D1-D4) prepared (Fig. 7 . internal deletion mutants expressed CBP fusions bacteria purified. binding eEF-1a cZPR1 proteins detected immuno-
blot analysis. frame deletions D1 (residues 222–
241) D2 (residues 222–261) effect eEF-1a
binding, deletions D3 (residues 202–241) D4
(residues 202–261) eliminated binding eEF-1a cZPR1 (Fig. 7 C). data suggest sequence 
quired eEF-1a binding present D3 region (res-
idues 202–241) cZPR1 (Fig. 7 . delineate       Figure 7. small region ZPR1 required interaction cZPR1 sequence required binding eEF-1a,         eEF-1a yeast S. cerevisiae.   Schematic representation smaller frame deletion mutant D5 (residues 202–         S. cerevisiae ZPR1. NH2-terminal (NT; residues 1–261) 221) prepared tested eEF-1a binding. Immuno-       COOH-terminal (CT; residues 262–486) fragments cZPR1 blot analysis demonstrated cZPR1 deletion             illustrated. frame deletions length cZPR1 pro-
                                                               tein constructed: D1 (residues 222–241), D2 (residues 222–
mutant D5 did bind eEF-1a (Fig. 7 D).                                                                 261), D3 (residues 202–241), D4 (residues 202–261), D5 (res-
20-amino acid region D5 (residues 202–221) required        idues 202–221). sequence D5 region mouse present length truncated ZPR1 eEF-       yeast ZPR1 proteins illustrated. (B–D) Recombinant cZPR1
1a binding. region located domain      proteins expressed CBP fusion protein bacteria. cZPR1 protein conserved mouse, S. cerevisiae     CBP fusion proteins purified, immobilized, used S. pombe (Fig. 7 .                                       binding assays using cell lysates. Bound eEF-1a detected
                                                               protein immunoblot analysis. binding eEF-1a NT
Mutational Analysis ZPR1 Function                           CT fragments cZPR1 examined (B). effect 
                                                               frame deletions (D1, D2, D3, D4) cZPR1 investigated examined effect cZPR1 mutations disrupt         (C). effect D5 frame deletion mutation cZPR1
eEF-1a binding viability S. cerevisiae.       examined (D).
frame deletion mutants D1, D2, D3, D4, D5 comple-
mented loss viability caused disruption cZPR1 gene S. cerevisiae (Table IV). data indi-
cate deletion sequences required eEF-1a bind-




Gangwani et al. Interaction ZPR1 eEF-1a                 1479
 Table IV. Mutational Analysis Effect ZPR1 Yeast                          periments demonstrated cZPR1 mutants D1 Viability Interaction ZPR1 eEF-1a                                     D2, bind eEF-1a, exhibited growth defect (Fig. 8
ZPR1                                   Complementation             eEF-1a binding     . contrast, yeast strains (Table II) expressing mu-
                                                                                      tant cZPR1 (D3, D5, CT) proteins bind plasmid p413 ADH                         2                          2           eEF-1a (Table IV) grow 20-fold
WT                                             1                          1
                                                                                      slower yeast expressing wild-type cZPR1 (Fig. 8, D1                                             1                          1
D2                                             1                          1
                                                                                      B).
D3                                             1                          2              morphology yeast strains expressing wild-
D3 1 NT                                        1                          1           type mutant cZPR1 proteins examined light
D5                                             1                          2           microscopy. Fig. 8 C shows images yeast expressing
D5 1 NT                                        1                          1           wild-type cZPR1 mutant D5 cZPR1 does bind
NT                                             2                          1           eEF-1a. Cells mutant cZPR1 (D5) larger CT                                             1                          2           grow chain-like clusters. failure cells sepa-
CT 1 NT                                        1                          1           rate larger size suggest slow-growing
CT 1 NT (DD5)                                  1                          2           yeast accumulate G2/M phase cell cycle.
MtZnF1                                         1                          1
                                                                                      cells examined DNA content MtZnF2                                         2                          1
                                                                                      flow cytometry. Fig. 8 C shows wild-type cells Viability haploid yeast (zpr1::LEU2) transformed plasmid expression vectors   distributed G1 G2 phases cell cy- wild-type mutated ZPR1 proteins scored positive (1) negative (2).
Binding recombinant ZPR1 eEF-1a detected vitro (1, 2).
                                                                                      cle, corresponding 1N 2N DNA content, respec-
                                                                                      tively (Fig. 8 C). contrast, majority mutant
                                                                                      yeast cells contained 2N DNA (Fig. 8 D), consistent                                                                                       accumulation G2/M phase cell cycle (Fig. 8
ing did affect essential role ZPR1 required                            C). data suggest interaction cZPR1 viability.  binding cZPR1 eEF-1a                              eEF-1a required normal cell cycle progression. required viability S. cerevisiae.                                             examine absence binding eEF-1a    performed deletion analysis identify region                           relevant defective growth yeast strains ex-
cZPR1 required yeast viability. Expression                            press mutant cZPR1 molecules (D3, D5, CT),  NT fragment cZPR1 (residues 1–261),                                    formed interallelic complementation assay. NT
cludes zinc finger region required                           fragment cZPR1 binds eEF-1a, sufficient teraction eEF-1a, did confer viability (Table IV).                           viability.  expression NT fragment contrast, expression CT fragment cZPR1 (resi-                              cZPR1 D3, D5, CT mutant ZPR1 yeast strains
dues 262–486), includes second zinc finger                              restored normal proliferation (Fig. 8, B). 
does interact eEF-1a, able confer viability                           firm restoration normal growth 
(Table IV). data demonstrate functions                              teraction ZPR1 eEF-1a, yeast strain expressing
cZPR1 bind eEF-1a confer viability encoded                              CT fragment transformed plasmid express- separate regions cZPR1 gene. eEF-1a bind-                               ing NT (DD5) fragment cZPR1 does bind
ing requires NT fragment cZPR1 viability                                eEF-1a. Expression NT (DD5) did restore growth
quires CT fragment cZPR1.                                                      yeast complemented CT fragment    examine sequences present CT                                 cZPR1 (Fig. 8 B). data consistent hy-
fragment cZPR1 required viability, ex-                             pothesis interaction cZPR1 eEF-1a amined effect mutations cZPR1 zinc fingers.                             required normal growth yeast. specificity zinc fingers disrupted replacing                               D5 mutation cause reduced growth tested Cys residues Ala. Mutation zinc finger 1 (located                          comparison effect mutation zinc fin- NT fragment cZPR1) complemented loss                                ger cZPR1 (replacement Cys residues bility caused disruption ZPR1 gene. contrast,                            Ala). Mutation zinc finger caused slow growth
mutation second zinc finger (present CT                                 associated accumulation G2/M
region cZPR1) did confer viability assay (Ta-                          phase cell cycle (data shown).  G2/M ac-
ble IV). data indicate sequences located                            cumulation caused D5 mutation does represent
CT required viability include second zinc                            nonspecific consequence defects cZPR1 function.
finger.                                                                                  examine effect NT fragment                                                                                       cZPR1 restore normal growth yeast express
Interaction ZPR1 eEF-1a Required                                       D5 mutant cZPR1, studied effect cZPR1 mu-
Normal Growth                                                                         tations subcellular localization cZPR1 S. cere- interaction cZPR1 eEF-1a did appear                                visiae. GFP-labeled NT CT fragments cZPR1 essential viability yeast S. cerevisiae (Table                          (NT–GFP CT–GFP), like wild-type cZPR1-GFP, IV).  ZPR1 eEF-1a interact response                                 accumulate nucleus (Fig. 8 E). dis-
extracellular growth stimuli (Fig. 4, B C).                          tribution D5 mutant cZPR1-GFP (D5–GFP) was possible interaction play role                             similar wild-type cZPR1–GFP (Fig. 8 E).  
normal process cellular proliferation. examine                              letion D5 region did affect nuclear distribu-
function ZPR1/eEF-1a complex cellular growth,                               tion cZPR1 growing cells. data demonstrate investigated effect cZPR1 mutations disrupt                            cZPR1 accumulate nucleus independently
eEF-1a binding growth S. cerevisiae. Control ex-                            eEF-1a.



 Journal Cell Biology, Volume 143, 1998                                         1480
 Figure 8. Mutational analysis effect ZPR1 growth yeast S. cerevisiae.   growth haploid yeast strains
(zpr1::LEU2) complemented plasmid expression vectors wild-type (WT) mutated (D1, D2, D3, D5, NT) cZPR1 examined. Liquid cultures yeast (0.2 OD600) serially diluted 5-, 10-, 50-, 100- 1,000-fold, spotted YEPD plates, incubated 308C. (B) growth haploid yeast strains (zpr1::LEU2) complemented plasmid expression vectors wild-type (WT) mutated (CT, NT, NTDD5) cZPR1 examined described  (C) Morphology haploid yeast strains
(zpr1::LEU2) complemented plasmid expression vectors WT cZPR1 (strain LY1) mutant D5 cZPR1 (strain LY6) ex-
amined microscopy using Nomarski optics. DNA detected DAPI staining fluorescence microscopy. (D) FACS® analysis haploid yeast strains LY1 LY6 expressing wild-type mutant (D5) cZPR1, respectively. (E) Mutational analysis sub-cellular localization cZPR1 S. cerevisiae. location wild-type cZPR1 (cZPR1-GFP), D5 mutant cZPR1 (D5-GFP), NT fragment cZPR1 (NT-GFP), CT fragment cZPR1 (CT-GFP) examined fluorescence microscopy yeast strains
MY28, LY11, LY12, LY14, respectively (Table II). Bars: (C) 50 mm; (E) 10 mm.




Gangwani et al. Interaction ZPR1 eEF-1a                        1481
 Discussion                                                       polymerase  splicing factor SC35 p80
                                                                 coilin (Galcheva-Gargova et al., 1998). colocalization
ZPR1 Conserved Mammals Yeast                           fibrillarin RNA polymerase suggests ZPR1
                                                                 accumulates nucleoli.
ZPR1 zinc finger protein initially identified     ZPR1 known redistribute mammals (Galcheva-Gargova et al., 1996). protein            cytoplasm nucleus mammalian cells (Galcheva-
contains zinc fingers primary structure: Cys-       Gargova et al., 1996), unclear subcellu-
Xaa2-Cys-Xaa25-Cys-Xaa2-Cys. Atomic absorption spec-             lar localization ZPR1 regulated yeast. troscopy confirmed presence zinc atoms        demonstrate ZPR1 redistributes cyto-
ZPR1 molecule (Galcheva-Gargova et al., 1996).           plasm nucleus yeast S. cerevisiae. prolifer-
demonstrate ZPR1 protein conserved bud-           ating yeast, ZPR1 protein located preferentially ding yeast (S. cerevisiae) fission yeast (S. pombe).       nucleus. contrast, nutrient deprivation yeast, like
homologue ZPR1 identified nematode            serum starvation mammalian cells, caused redistri-
Caenorhabditis elegans searching GenBank data-            bution ZPR1 nucleus cytoplasm. base (Wilson et al., 1994; GenBank/EMBL/DDBJ acces-              data indicate ZPR1 responds proliferative signals
sion number AF022981) using BLAST File Server                mammals yeast. studies required
(National Center Biotechnology Information,               determine mechanism nuclear exclusion nu-
thesda, MD). conserved structure ZPR1 pro-            clear accumulation response altered proliferative
teins diverse species indicates ZPR1         states.
protein similar functions higher lower eu-
karyotes.
   examine function ZPR1 eukaryotic cells, studied role yeast S. cerevisiae. Gene disruption     Interaction ZPR1 eEF-1a experiments demonstrated ZPR1 essential vi-         Mitogen-treated Cells
ability S. cerevisiae. Deletion analysis genetic com-     ZPR1 protein bind eEF-1a. Coimmuno-
plementation assays demonstrated COOH-termi-            precipitation analysis demonstrated ZPR1 did nal region ZPR1 (including second zinc finger)        interact eEF-1a serum-starved mammalian cells.
required viability. contrast, NH2-terminal region     contrast, treatment EGF serum caused rapid  ZPR1 (including zinc finger) dispensable        duction ZPR1 complex formation eEF-1a. Control yeast viability.                                             studies demonstrated formation ZPR1/eEF-1a
   requirement COOH-terminal region               complexes selective treatment cells
cZPR1 yeast viability evolutionary signifi-         phorbol ester did cause coimmunoprecipitation
cance. Prokaryotic homologues ZPR1              eEF-1a ZPR1. data indicate described.  prokaryotes contain homo-              ZPR1 interacts cell surface receptors quiescent
logue COOH-terminal region ZPR1. Conceptual            cells (Galcheva-Gargova et al., 1996), ZPR1 binds eEF-
translation genomic sequences bacteria,        1a treatment cells certain extracellular
including Escherichia coli (Taura et al., 1992; GenBank/         stimuli.
EMBL/DDBJ accession number P25538), Synechococcus                   eEF-1a preferentially located cytoplasm cells
sp. (Sugita et al., 1995; GenBank/EMBL/DDBJ accession            (Edmonds et al., 1996; Minella et al., 1996). contrast,
number P46227), Methanococcus jannaschii (Bult et al.,           ZPR1 located nucleus mitogen-activated cells
1996; GenBank/EMBL/DDBJ accession number O57950),                (Galcheva-Gargova et al., 1996). cytoplasmic location
Archaeoglobus fulgidus (Klenk et al., 1997; GenBank/             eEF-1a incompatible evidence nuclear
EMBL/DDBJ accession number AE00150), Methano-                ZPR1 mitogen-activated cells forms complexes bacterium thermoautotrophicum (Smith et al., 1997; Gen-          eEF-1a. eEF-1a abundant cellular protein, Bank/EMBL/DDBJ accession number AE000936) indi-                  considered possibility population eEF-1a
cates presence conserved hypothetical protein           molecules form complexes ZPR1 represents zinc finger similar COOH-terminal region         fraction total eEF-1a present cell. ZPR1. hypothetical prokaryotic zinc fin-        test hypothesis, examined nuclear accumula-
ger proteins share functions similar eukary-     tion eEF-1a serum-starved EGF-treated cells.
otic ZPR1 proteins presently unclear, warrants fur-       analysis demonstrated nuclear eEF-1a ther study.                                                      detected starved cells, detected EGF-treated
                                                                 cells. Interestingly, nuclear eEF-1a exhibited punc-
                                                                 tate immunofluorescence appearance similar                                                                  ZPR1. data consistent hypothesis Nuclear Redistribution ZPR1 Proliferating Cells            mitogen-treatment cells caused formation nu- ZPR1 protein located cytoplasm quiescent        clear complexes ZPR1 eEF-1a. evidence
mammalian cells redistributes nucleus           support interpretation obtained ob-
treatment mitogens (Galcheva-Gargova et al., 1996).         servation treatment cells phorbol ester,
Immunofluorescence analysis demonstrated nu-            does cause formation ZPR1/eEF-1a
clear ZPR1 protein exhibited punctate appearance. Dou-         complexes, did cause punctate nuclear localization ble-label immunofluorescence microscopy demonstrated             eEF-1a. nuclear ZPR1 colocalized fibrillarin RNA              preferential location eEF-1a cytoplasm 


 Journal Cell Biology, Volume 143, 1998                    1482
 established (Edmonds et al., 1996; Minella et al., 1996)                    Nolan, L  Herzenberg. 1996. Simultaneous fluorescence-activated cell
                                                                                sorter analysis distinct transcriptional elements single cell  presence nuclear subpopulation eEF-1a                           ing engineered green fluorescence proteins. Proc. Natl. Acad. Sci. USA. 93: described (Collig et al., 1994; Janssen et al., 1994;                      8508–8511.
Barberse et al., 1995; Billaut-Mulot et al., 1996; Sanders et                Barbarese, E., D.E. Koppel, M.P. Deutscher, C.L. Smith, K. Ainger, F. Morgan,
                                                                                J.H. Carson. 1995. Protein translation components colocalized al., 1996). populations eEF-1a play dif-                       granules oligodendrocytes. J. Cell Sci. 108:2781–2790.
ferent physiological roles. results study demon-                 Billaut-Mulot, O., R. Fernandez-Gomez, M. Loyens,  Ouaissi. 1996. Try-
                                                                                panosoma cruzi elongation factor-1a: nuclear localization parasites 
strate nuclear eEF-1a includes complexes eEF-1a                         going apoptosis. Gene. 174:19–26. ZPR1 proliferating cells. Previous studies eEF-                   Blackwell, J.L., M  Brinton. 1997. Translation elongation factor-1 alpha
1a indicate bind RNA (Blackwell Brinton,                        interacts 39 stem-loop region West Nile virus genomic RNA. J. Virol.
                                                                                71:6433–6444.
1997) interacts RNA polymerase poly-                        Blumenthal, T., G.G. Carmichael. 1979. RNA replication: function merases (Blumenthal Carmichael, 1979; Das et al.,                           structure Qb-replicase. Ann. Rev. Biochem. 48:528–548.
1998). possible role nucleolar complex eEF-                    Bult, C.J., O. White, G.J. Olsen, L. Zhou, R.D. Fleischmann, G.G. Sutton, J 
                                                                                Blake, L.M. Fitzgerald, R  Clayton, J.D. Gocayne, et al. 1996. Complete
1a ZPR1 functionally interact, directly                        genome sequence methanogenic archaeon Methanococcus jannaschii.
directly, RNA. eEF-1a GTPase activity                              Science. 273:1058–1073.
                                                                             Christianson, T.W., R.S. Sikorski, M. Dante, J.H. Shero, P. Hieter. 1992.
contribute putative regulatory function                          Multifunctional yeast high-copy number shuttle vectors. Gene. 110:119–122.
ZPR1/eEF-1a complex.                                                         Colling, D , G.O. Wastenays, M. Miyazaki, R.E. Williamson. 1994. Elon-
                                                                                gation factor 1a component subcortical actin bundles characean
                                                                                algae. Cell Biol. Int. 18:1019–1024.
Interaction ZPR1 eEF-1a Required                              Condeelis, J. 1995. Elongation factor 1 alpha, translation cytoskeleton.
Normal Cellular Proliferation                                                   Trends Biochem. Sci. 20:169–170.
                                                                             Das, T., M. Mathur, K. Gupta, G.M.C. Janssen, K. Banerjee. 1998.
Deletion analysis demonstrated short segment                          RNA polymerase vesicular stomatitis virus specifically associates                                                                                 translation elongation factor-1abg activity. Proc. Natl. Acad. Sci. NH2-terminal region ZPR1 required                         USA. 95:1449–1454.
teraction ZPR1 eEF-1a. COOH-termi-                         Edmonds, B.T., J. Wyckoff, Y.-G. Yeung, Y. Wang, R.E. Stanley, J. Jones, J.
nal region ZPR1 sufficient yeast viability,                       Segall, J. Condeelis. 1996. Elongation factor-1a overexpressed ac-
                                                                                tin binding protein metastatic rat mammary adenocarcinoma. J. Cell Sci.
conclude interaction ZPR1 eEF-1a                        109:2705–2714.
required viability. conclusion strongly sup-                    Galcheva-Gargova, , K.N. Konstantinov, H.  Wu, F.G. Klier, T. Barrett,
ported observation small frame deletions,                        R.J. Davis. 1996. Binding zinc finger protein ZPR1 epidermal
                                                                                growth factor receptor. Science. 272:1797–1802. disrupt binding eEF-1a, did affect ability                  Galcheva-Gargova, , L. Gangwani, K.N. Konstantinou, M. Mikrut, S.J.  ZPR1 confer viability.  yeast strains ex-                         roux, T. Enoch, R.J. Davis. 1998. cytoplasmic zinc finger protein
                                                                                ZPR1 accumulates nucleolus proliferating cells. Mol. Biol. Cell.
pressing ZPR1 proteins did bind eEF-1a                            9:2963–2971. exhibit slow growth, aberrant morphology,                    Janssen, G.M.C., H.T.F. Van Damme, J. Kriek, R. Amons, W. Moller.
accumulate G2/M phase cell cycle. data                      1994. subunit structure elongation factor 1 Artemia salina;                                                                                 chains complex. J. Biol. Chem. 269:1–8.
indicate interaction ZPR1 eEF-1a                     Klenk, H.P., R  Clayton, J. Tomb, O. White, K.E. Nelson, K  Ketchum,
required normal proliferation yeast. tested                       R.J. Dodson, M. Gwinn, E.K. Hickey, J.D. Peterson, et al. 1997. com- hypothesis performing interallelic complemen-                        plete sequence hyperthermophilic, sulphate-reducing, archaeon Ar-
                                                                                chaeoglobus fulgidus. Nature. 390:364–370.
tation assay using NH2-terminal fragment ZPR1                          Krieg, P , S.M. Varnum, W.M. Wormington, D  Melton. 1989. binds eEF-1a, insufficient viability.                  mRNA encoding elongation factor-1a (eEF-1a) major transcript                                                                                 midblastula transition Xenopus. Dev. Biol. 133:93–100.
fragment ZPR1 complemented defective growth                        Lew, D.J., N.J. Marini, S  Reed. 1992. Different G1 cyclins control yeast strains express ZPR1 proteins bind                       timing cell cycle commitment mother daughter cells budding
eEF-1a. contrast, deletion sequences required                         yeast S. cerevisiae. Cell. 69:317–327.
                                                                             Minella, O., O. Mulner-Lorillon, V. Smedt, S. Hourdez, P. Cormier, R.
eEF-1a binding NH2-terminal fragment ZPR1                             Belle. 1996. Major intracellular localization elongation factor-1. Cell Mol.
(NT DD5) blocked interallelic complementation.                        Biol. 42:805–810.
data provide strong support hypothesis                      Moldave, K. 1985. Eukaryotic protein synthesis. Ann. Rev. Biochem. 54:1109–
                                                                                1149.
binding ZPR1 eEF-1a required normal cellular                    Rose, M.D., P. Novick, J.H. Thomos, D. Botstein, G.R. Fink. 1987. Saccha-
proliferation. studies required determine                        romyces cerevisiae genomic plasmid bank based centromere containing
                                                                                shuttle vector. Gene. 50:237–243. ZPR1/eEF-1a complex required prolif-                      Rothstein, R.J. 1983. step gene disruption yeast. Methods Enzymol. 101:
eration mammalian cells. addition, studies                         202–211.
quired establish molecular mechanism action                     Sanders, J., M. Brandsma, G.M.C. Janssen, J. Dijk, W. Moller. 1996. Immu-
                                                                                nofluorescence studies human fibroblasts demonstrate presence ZPR1/eEF-1a complex vivo.                                         